Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
In this phase I/II single (only participant) blinded pilot trial, we tested safety and efficacy of A. soehngenii in metabolic syndrome subjects and found that daily ingestion of increasing A. soehngenii doses for 1 month was associated with increased fecal levels of A. soehngenii with greatest efficacy in the subjects who received the highest dose. […] More